GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Gross-Profit-to-Asset %

Godavari Drugs (BOM:530317) Gross-Profit-to-Asset % : 27.63% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Godavari Drugs's annualized Gross Profit for the quarter that ended in Dec. 2023 was ₹351 Mil. Godavari Drugs's average Total Assets over the quarter that ended in Dec. 2023 was ₹1,272 Mil. Therefore, Godavari Drugs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 27.63%.


Godavari Drugs Gross-Profit-to-Asset % Historical Data

The historical data trend for Godavari Drugs's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs Gross-Profit-to-Asset % Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.25 24.14 29.80 31.84 28.33

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.79 28.17 24.22 27.63 27.63

Competitive Comparison of Godavari Drugs's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's Gross-Profit-to-Asset % falls into.



Godavari Drugs Gross-Profit-to-Asset % Calculation

Godavari Drugs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=315.671/( (1014.11+1214.33)/ 2 )
=315.671/1114.22
=28.33 %

Godavari Drugs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=351.388/( (1271.684+0)/ 1 )
=351.388/1271.684
=27.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Godavari Drugs Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines